Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?

Why Are We Still Talking About Hydroxychloroquine as a Treatment for COVID-19?

The use of hydroxychloroquine as a treatment for COVID-19 serves as an example of what is wrong with medical information being widely disseminated before it is thoroughly vetted by peer review. Preliminary studies of this treatment modality were spread widely, creating false hope that a treatment for COVID-19 existed. Several randomized trials have shown that hydroxychloroquine is not an effective therapy for COVID-19.

David Juurlink, MD, PhD, from the University of Toronto summarizes the evidence base regarding hydroxychloroquine and COVID-19.

Related Article(s):

Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19)

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(499)

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

An Overview of Postural Orthostatic Tachycardia Syndrome (POTS)

POTS is a chronic autonomic disorder characterized by excessive orthostatic tachycardia and multisystem symptoms that affects an estimated 0.1% to 1% of the US population. Author Satish Raj, MD, MSCI,...

24 Aug 28min

Medication Treatments for Alcohol Use Disorder

Medication Treatments for Alcohol Use Disorder

Naltrexone, acamprosate, disulfiram, and topiramate are effective but underused medications for treatment of alcohol use disorder. Author Stephen Holt, MD, MS, of Yale School of Medicine joins JAMA De...

19 Aug 20min

Liquid Biopsy Tests for Cancer

Liquid Biopsy Tests for Cancer

Circulating tumor DNA (ctDNA)(liquid biopsies) can help monitor cancer progression, detect residual cancer after treatment, and identify genetic changes within cancer cells that could affect treatment...

10 Aug 23min

Patient-Clinician Communication About Physical Activity

Patient-Clinician Communication About Physical Activity

Physical activity is an effective component of care for people with chronic medical conditions. In this podcast, JAMA Insights author Alessio Bricca, PhD, University of Southern Denmark, discusses ada...

6 Aug 10min

Classic Hodgkin Lymphoma

Classic Hodgkin Lymphoma

Hodgkin lymphoma is a relatively rare disease, with approximately 82 409 incident cases reported globally in 2022, and 8720 cases reported in the US in 2025. Author Alison Moskowitz, MD, of Memorial S...

3 Aug 20min

The Sleep-Weight Connection

The Sleep-Weight Connection

Suboptimal sleep quality and quantity are associated with higher body mass index and more difficulty losing weight. In this podcast, JAMA Insights author Atul Malhotra, MD, from the University of Cali...

29 Juli 13min

Management of Dyslipidemia

Management of Dyslipidemia

Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of global mortality and is strongly associated with cumulative exposure to atherogenic lipoproteins across the lifespan. Author A...

20 Juli 23min

Hip Fractures: Management and Prevention

Hip Fractures: Management and Prevention

Hip fractures are a leading cause of disability and death in older adults. This episode summarizes  risk factors, prevention, and medical and surgical management of  hip fractures. JAMA Deputy Editor ...

16 Juli 19min

Populärt inom Vetenskap

p3-dystopia
dumma-manniskor
rss-mottagningen
allt-du-velat-veta
kapitalet-en-podd-om-ekonomi
ufo-sverige
rss-ronden
det-morka-psyket
halsorevolutionen
rss-spraket
sexet
rss-vetenskapsradion
rss-odla
svd-nyhetsartiklar
ufo-sverige-2
medicinvetarna
paranormalt-med-caroline-giertz
bildningspodden
rss-arkeologi-historia-podden-som-graver-i-vart-kulturlandskap
vetenskapsradion